These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 6442760)

  • 1. Barbiturate tolerance and physical dependence: contribution of pharmacological factors.
    Okamoto M
    NIDA Res Monogr; 1984; 54():333-47. PubMed ID: 6442760
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ethanol and barbiturate physical dependence.
    Okamoto M; Hinman DJ; Aaronson LM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):701-8. PubMed ID: 7196450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of functional tolerance during barbiturate physical dependency production.
    Okamoto M; Boisse NR; Rosenberg HC; Rosen R
    J Pharmacol Exp Ther; 1978 Dec; 207(3):906-15. PubMed ID: 569696
    [No Abstract]   [Full Text] [Related]  

  • 5. Physical dependence to barbital compared to pentobarbital. III. Withdrawal characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):514-25. PubMed ID: 564952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical dependence to barbital compared to pentobarbital. IV. Influence of elimination kinetics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):526-40. PubMed ID: 564953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical dependence to barbital compared to pentobarbital. I. "Chronically equivalent" dosing method.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):497-506. PubMed ID: 564950
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of dosing frequency on the development of physical dependence and tolerance to pentobarbital.
    Okamoto M; Rao S; Walewski JL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1004-8. PubMed ID: 3746655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmotic minipumps for administration of barbital to mice: demonstration of functional tolerance and physical dependence.
    Siew C; Goldstein DB
    J Pharmacol Exp Ther; 1978 Mar; 204(3):541-6. PubMed ID: 564954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of individual variations in drug elimination kinetics for production of pentobarbital physical dependence.
    Okamoto M; Hinman DJ
    J Pharmacol Exp Ther; 1983 Jul; 226(1):52-6. PubMed ID: 6683313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical dependence produced by long duration, low dose chronic barbital treatment.
    Okamoto M; Hinman DJ
    Subst Alcohol Actions Misuse; 1984; 5(2):97-103. PubMed ID: 6540898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of alcohol and barbital physical dependence in mice.
    Kaneto H; Kaneda H; Kawatani S
    Yakubutsu Seishin Kodo; 1987 Jun; 7(2):327-32. PubMed ID: 3687245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical dependence capacity of brotizolam in rhesus monkeys. 2nd communication: primary dependence and barbital substitution.
    Stockhaus K
    Arzneimittelforschung; 1986 Mar; 36(3A):601-5. PubMed ID: 3718584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chronic barbitone administration and withdrawal on the sensitivity of the central nervous system to barbiturate.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1969 Oct; 37(2):502P-503P. PubMed ID: 5388578
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ; Morgan WW
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for the rapid induction of barbiturate tolerance.
    Mann PA; Isom GE
    Proc West Pharmacol Soc; 1978; 21():387-90. PubMed ID: 693521
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of neurochemical tolerance following chronic barbital treatment.
    Lane SJ; Morgan WW
    Neurobehav Toxicol Teratol; 1985; 7(2):195-7. PubMed ID: 2987720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated withdrawal from barbital as a drive for 'drug taking behavior' in rats.
    Jänicke UA; Coper H
    Drug Alcohol Depend; 1984 Jan; 13(1):43-54. PubMed ID: 6539666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study on development of physical dependence on alcohol and cross physical dependence liability of diazepam and barbital to alcohol in rhesus monkeys (author's transl)].
    Miyasato K
    Seishin Shinkeigaku Zasshi; 1978 Dec; 80(12):657-67. PubMed ID: 108696
    [No Abstract]   [Full Text] [Related]  

  • 20. Sleep patterns in cats during chronic low-dose barbiturate treatment and withdrawal.
    Hinman DJ; Okamoto M
    Sleep; 1984; 7(1):69-76. PubMed ID: 6538986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.